Glaucoma

  • For general guidance on administration of drugs to the eye and control of microbial contamination of eye drops, please see the ‘General information on eye drops’ section.
  • Compliance aids are available to fit most bottles and single dose vials. Information on the various aids and what they fit is available from the Glaucoma UK website.
  • Offer preservative-free eye drops to patients who have an allergy to preservatives, or patients with clinically significant and symptomatic ocular surface disease. Preservative-free drops should also be considered in patients who are likely to require, or who have undergone glaucoma filtering surgery. All drugs should be prescribed generically.

Step 1 treatment of raised intra-ocular pressure with prostaglandin analogues

Preservative-free eye drops are restricted to use in patients who have an allergy to preservatives, or patients with clinically significant and symptomatic ocular surface disease.

Latanoprost
Latanoprost 50micrograms/ml eye drops

Instil once daily, preferably in the evening.

Latanoprost 50micrograms/ml eye drops 0.2ml unit dose preservative free

Instil once daily, preferably in the evening.

Preservative-free eye drops are restricted to use in patients who have an allergy to preservatives, or patients with clinically significant and symptomatic ocular surface disease.

Travoprost
Travoprost 40micrograms/ml eye drops

Instil once daily, to be administered preferably in the evening.

Travoprost 40micrograms/ml eye drops 0.1ml unit dose preservative free

Instil once daily, to be administered preferably in the evening.

Bimatoprost
Bimatoprost 100micrograms/ml eye drops

Instil once daily, to be administered preferably in the evening.

Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free

Instil once daily, to be administered preferably in the evening.

Bimatoprost 300micrograms/ml eye drops preservative free

Instil once daily, to be administered preferably in the evening.

Prescribing Notes:

  • Open-angle glaucoma and treated angle-closure glaucoma are not contra-indications to the use of oral drugs that have anticholinergic effects.
  • Prostaglandin analogues may cause an increase in brown iris pigment. Following cataract surgery they may cause macular oedema but cataract surgery is not a contraindication for prostaglandin analogue.
  • Prostaglandin analogues may initially cause conjunctival hyperaemia and may persist longer with bimatoprost. This should not be painful and wears off (usually about one week) as the eye becomes accustomed to the drops.
  • At each stage, consideration should be given to withdrawing a drug if there is no significant pressure response.
  • Prostaglandin analogues should be prescribed generically.
  • Latanoprost is available as a generic and is the preferred prostaglandin analogue.

History Notes

10/07/2024

Addition of travoprost preservative free, prescribing information updated, ERWG July 24.

15/06/2022

East Region Formulary content agreed.

Step 2 treatment of raised intra-ocular pressure with beta blockers

If beta-blocker is not contraindicated.

Timolol
Timolol 0.25% eye drops

Instil twice daily.

Timolol 2.5mg/ml eye drops preservative free

Instil twice daily.

Gel formulation for use when patient compliance is a problem.

Timolol
Timolol 0.25% eye gel

Instil once daily.

Timolol 1mg/g gel eye drops 0.4g unit dose preservative free

Instil one drop, once daily in the morning.

Prescribing Notes:

  • Please see the combination pathway if a combination product is required.
  • Systemic absorption can follow topical application and contra-indications for beta-blockers are therefore asthma, bradycardia and uncontrolled heart failure. This applies to all topical beta-blockers. It is advisable to take necessary steps to reduce systemic absorption as suggested in the drops instillation technique.
  • Timolol 0.5% eye drops have no advantage over 0.25% eye drops. The 0.25% eye drops are just as effective with less chance of side-effects. Combination products containing timolol are only available as 0.5% strength eye drops.
  • Compliance can be an issue and combination drops may be useful as there is often no significant additional cost compared with the individual components and it allows the patient to administer fewer drops. If combination prostaglandin / beta blocker drops are appropriate bimatoprost 0.03%/timolol 0.5% should be prescribed. Clinical experience is that these may be more effective than latanoprost/timolol combination drops.
  • At each stage, consideration should be given to withdrawing a drug if there is no significant pressure response.
  • A once daily gel formulation of timolol (Timolol 0.25% eye gel) is available for use when patient compliance is a problem.

History Notes

09/10/2023

Addition of Timolol 1mg/g eye gel drops 0.4g preservative free unit dose, ERFC June 2023.

15/06/2022

East Region Formulary content agreed.

Step 2 treatment of raised intra-ocular pressure if beta blockers contraindicated

If beta-blocker is contraindicated.

Brinzolamide
Brinzolamide 10mg/ml eye drops

Instil twice daily. May be increased to 3 times daily if used as monotherapy.

Dorzolamide
Dorzolamide 20mg/ml eye drops

Instil twice daily. May be increased to 3 times daily if used as monotherapy.

Dorzolamide 20mg/ml eye drops preservative free

Instil twice daily. May be increased to 3 times daily if used as monotherapy.

Dorzolamide 20mg/ml eye drops 0.2ml unit dose preservative free

Instil twice daily. May be increased to 3 times daily if used as monotherapy.

Prescribing Notes:

  • Please see the combination pathway if a combination product is required.
  • Allergy to topical carbonic anhydrase inhibitors is fairly common.
  • Acetazolamide can be given orally but long-term use is not advisable because of side-effects. These include metabolic acidosis and electrolyte imbalance; renal calculi; paraesthesia; headache and malaise; gastro-intestinal upset; blood dyscrasias.
  • At each stage, consideration should be given to withdrawing a drug if there is no significant pressure response.

History Notes

15/06/2022

East Region Formulary content agreed.

Step 3 treatment of raised intra-ocular pressure

If patient using, or has used, a prostaglandin analogue and a beta blocker.

Brinzolamide
Brinzolamide 10mg/ml eye drops

Instil twice daily. May be increased to 3 times daily if used as monotherapy.

If patient using, or has used, a prostaglandin analogue and a beta blocker.

Dorzolamide
Dorzolamide 20mg/ml eye drops

Instil twice a day, or three times a day if monotherapy.

Dorzolamide 20mg/ml eye drops preservative free

Instil twice a day, or three times a day if monotherapy.

Dorzolamide 20mg/ml eye drops 0.2ml unit dose preservative free

Instil twice a day, or three times a day if monotherapy.

If patient using, or has used, a prostaglandin analogue and brinzolamide.
OR if patient using, or has used, a prostaglandin analogue, and a beta blocker and brinzolamide.

Brimonidine
Brimonidine 0.2% eye drops

Instil twice daily.

Prescribing Notes:

  • Please see the combination pathway if a combination product is required.
  • Brinzolamide and timolol combination allows patients to administer fewer drops compared to separate administration of the constituents.
  • Allergy to brimonidine is common. It should not be used by patients on tricyclic antidepressants or MAOIs, or in children under 5 years.
  • Brimonidine may cause ocular allergic reactions in approximately 15% of patients, especially those with dry eyes. Normal onset of allergic reaction is 3-9 months after initiation of brimonidine.
  • Brinzolamide 10mg/ml / Brimonidine 2mg/ml combination eye drops allow patients to administer fewer drops compared to separate administration of the components. Due to the availability of generic brinzolamide and brimonidine this combination product is now more expensive than using the two separate components. It is also less well tolerated than the separate components.
  • Eylamdo preservative-free (dorzolamide and timolol) in a multi-dose bottle is available for those who require treatment with a combination of these agents for glaucoma and have a proven sensitivity to the preservative benzalkonium chloride. Multi-dose bottles are less expensive than single-dose vials.
  • At each stage, consideration should be given to withdrawing a drug if there is no significant pressure response.

History Notes

15/06/2022

East Region Formulary content agreed.

Treatment with combination products

If patient using, or has used a prostaglandin analogue, timolol and brinzolamide.

Bimatoprost + Timolol
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops

Instil once daily.

Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops preservative free

Instil once daily.

Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 0.4ml unit dose preservative free

Instil once daily.

Latanoprost + Timolol
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops

Instil once daily.

Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free

Instil once daily.

Travoprost + Timolol
Travoprost 40micrograms/ml / Timolol 5mg/ml eye drops

Instil once daily.

Brimonidine + Timolol
Brimonidine 2mg/ml / Timolol 5mg/ml eye drops

Instil twice daily.

Brinzolamide + Timolol
Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops

Instil twice daily.

Dorzolamide + Timolol
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops

Instil twice daily.

Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free

Instil twice daily.

Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops preservative free

Instil twice daily.

Note – this combination product is more expensive and less well tolerated than using brinzolamide and brimonidine as separate components.

Brinzolamide + Brimonidine
Brinzolamide 10mg/ml / Brimonidine 2mg/ml eye drops

Instil 1 drop twice daily.

Prescribing Notes:

  • Allergy to brimonidine is common. It should not be used by patients on tricyclic antidepressants or MAOIs, or in children under 5 years. Brimonidine may cause ocular allergic reactions in approximately 15% of patients, especially those with dry eyes. Normal onset of allergic reaction is 3-9 months after initiation of brimonidine.
  • Brinzolamide 10mg/ml / Brimonidine 2mg/ml combination eye drops allow patients to administer fewer drops compared to separate administration of the constituents. Due to the availability of generic brinzolamide and brimonidine this combination product is now more expensive than using the two separate components. It is also less well tolerated than the separate components.
  • Brinzolamide and timolol combination allows patients to administer fewer drops compared to separate administration of the constituents.
  • Eylamdo preservative-free (dorzolamide and timolol) in a multi-dose bottle is available for those who require treatment with a combination of these agents for glaucoma and have a proven sensitivity to the preservative benzalkonium chloride.
  • Multi-dose bottles are less expensive than single-dose vials.
  • At each stage, consideration should be given to withdrawing a drug if there is no significant pressure response.
  • This combination product could be considered in patients with preservative allergy or ocular surface disease in whom stand-alone prostaglandin analogues are not sufficient.

History Notes

15/06/2022

East Region Formulary content agreed.

Step 4 treatment for specialist initiation only
Pilocarpine
Pilocarpine hydrochloride 1% eye drops

Use up to four times daily.

Pilocarpine hydrochloride 2% eye drops

Use up to four times daily.

Pilocarpine nitrate 2% eye drops 0.5ml unit dose preservative free

Use up to four times daily.

Oral medication should not be given long term. Contra-indicated in patients allergic to sulphonamides.

Acetazolamide
Acetazolamide 250mg tablets

By mouth using immediate release medicines, 250mg-1g daily. Doses over 250mg daily given in divided doses.

Acetazolamide 500mg powder for solution for injection vials

Specialist advice for hospital use only.

Acetazolamide 250mg modified-release capsules

By mouth using modified-release medicines – 250mg-500mg daily.

Apraclonidine
Apraclonidine 5mg/ml eye drops

Instil 1 drop 3 times a day usually for maximum 1 month due to effects wearing off after a few weeks, 5mg/ml eye drops to be administered, may not provide additional benefit if patient already using two drugs that suppress the production of aqueous humour.

Prescribing Notes:

  • Pilocarpine causes a small pupil which can compromise visual acuity.
  • Headache is a frequent symptom in the first few days of pilocarpine treatment. Advise simple analgesics.
  • At each stage, consideration should be given to withdrawing a drug if there is no significant pressure response.

History Notes

15/06/2022

East Region Formulary content agreed.

Adjuvant treatment
Betaxolol
Betaxolol 0.25% eye drops

Apply one drop twice daily

Before initiating treatment, the patient and carers should be advised of the possible change in eye colour

Travoprost
Travoprost 40micrograms/ml eye drops

2months-18years, apply once daily, preferable in the evening

If beta-blocker is contraindicated, but should not be given long term. Contra-indicated in patients allergic to sulphonamides.

Acetazolamide
Acetazolamide 250mg tablets

Birth-12 years, 5mg/kg 4 times daily by mouth. Max. 750mg daily. Over 12 years, 250mg 2-4 times daily by mouth. Max. 1g daily.

Acetazolamide 250mg modified-release capsules

Child 12-17 years 250mg to 500mg daily.

Acetazolamide 500mg powder for solution for injection vials

Birth-12 years, 5mg/kg 4 times daily by intravenous injection. Max. 750mg daily. Over 12 years, 250mg 2-4 times daily by intravenous injection. Max. 1g daily.

Acetazolamide 125mg/5ml oral solution

Birth-12 years, 5mg/kg 4 times daily by mouth. Max. 750mg daily. Over 12 years, 250mg 2-4 times daily by mouth. Max. 1g daily.

Prescribing Notes:

  • Acetazolamide can be given orally but long-term use is not advisable because of side-effects. These include metabolic acidosis and electrolyte imbalance; renal calculi; paraesthesia; headache and malaise; gastro-intestinal upset; blood dyscrasias. The dose of acetazolamide should be reviewed after one week.

History Notes

29/09/2022

Doses changed to reflect formulations and route of administration.

29/07/2020

Content migrated from LJF website.